MASH WITH FIBROSIS
Clinical trials for MASH WITH FIBROSIS explained in plain language.
Never miss a new study
Get alerted when new MASH WITH FIBROSIS trials appear
Sign up with your email to follow new studies for MASH WITH FIBROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug shows promise in reversing liver scarring in major trial
Disease control Recruiting nowThis Phase 3 study tests a drug called efruxifermin in 1,650 people with non-cirrhotic NASH/MASH and moderate liver scarring (stage 2 or 3). Participants receive either the drug or a placebo as a weekly injection. The goal is to see if the drug can reverse liver inflammation and …
Matched conditions: MASH WITH FIBROSIS
Phase: PHASE3 • Sponsor: Akero Therapeutics, Inc • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Old heart drug could be new hope against fatty liver
Disease control Recruiting nowThis study tests whether a low dose of digoxin, a drug normally used for heart problems, can help people with a severe type of fatty liver disease called NASH (also known as MASH). The trial will involve 144 adults with biopsy-confirmed NASH and liver scarring. Participants will …
Matched conditions: MASH WITH FIBROSIS
Phase: PHASE2 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Could a common sugar fuel liver damage?
Knowledge-focused Recruiting nowThis trial asks whether fructose, a sugar found in fruit and processed foods, causes more liver inflammation in people with MASH (a serious fatty liver disease) than in those with milder fatty liver or no liver disease. Over four weeks, participants follow a low-sugar diet and th…
Matched conditions: MASH WITH FIBROSIS
Phase: NA • Sponsor: Queen Mary University of London • Aim: Knowledge-focused
Last updated Aug 02, 2026 00:00 UTC